Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon Picking Up Momentum for New Phase
Minyanville
Wednesday, September 23, 2009 - 10:06am
tags:
Dendreon, Provenge, prostate cancer
Drugmaker Wyeth sues FDA for injunction to stop generic antibiotic it says could harm patients
Yahoo/AP
Wednesday, September 23, 2009 - 10:04am
tags:
Wyeth, FDA, antibiotics, Zosyn, generics, Orchid Healthcare
Roche's Avastin Misses Goal In Skin Cancer Study
WSJ Online
Wednesday, September 23, 2009 - 9:00am
tags:
Roche, Avastin, skin cancer
Onyx Breast Cancer Drug Continues to Dazzle
TheStreet.com
Wednesday, September 23, 2009 - 8:58am
tags:
breast cancer, ONYX Pharmaceuticals, Nexavar
Glaxo to stop funding commercial CME
Fierce Pharma
Wednesday, September 23, 2009 - 8:54am
tags:
CME, GSK
Antigenics, Cel-Sci Could Both Become Billion Dollar Companies
Seeking Alpha
Wednesday, September 23, 2009 - 8:44am
tags:
Antigenics, Cel-Sci, Oncophage, Multikine
Combinatorx Could Move Either Way on FDA Review Wednesday
Seeking Alpha
Wednesday, September 23, 2009 - 8:44am
tags:
FDA, CombinatoRx, Exalgo
Merck KGaA’s Erbitux Failed to Extend Lives in Study
Bloomberg
Wednesday, September 23, 2009 - 8:42am
tags:
Merck KGaA, Erbitux, Eli Lilly, colon cancer
Novo Nordisk: FDA diabetes-drug comment deferred
Marketwatch
Wednesday, September 23, 2009 - 8:40am
tags:
Novo Nordisk, FDA, diabetes, liraglutide
Johnson & Johnson: A Buy on Early Expansion Weakness
Seeking Alpha
Wednesday, September 23, 2009 - 8:38am
tags:
JNJ
What Google and Facebook Have to Do With the FDA
WSJ Online
Tuesday, September 22, 2009 - 9:03pm
tags:
FDA, social media
HIV Vaccine Study May Lift Hopes After Merck, Sanofi Setbacks
Bloomberg
Tuesday, September 22, 2009 - 8:38pm
tags:
HIV vaccines, Merck, Sanofi
FDA says tamper-proof OxyContin provides 'limited' benefit over original painkiller
Yahoo/AP
Tuesday, September 22, 2009 - 8:36pm
tags:
FDA, painkillers, oxycontin, Purdue
AstraZeneca Denied Drug’s Diabetes Link After Warning
Bloomberg
Tuesday, September 22, 2009 - 8:35pm
tags:
diabetes, AstraZeneca, Seroquel, antipsychotics
Pfizer and Wyeth Put the Horse Before the Cart
Motley Fool
Tuesday, September 22, 2009 - 8:15pm
tags:
Pfizer, Wyeth, animal health, Boehringer Ingelheim
AstraZeneca Tasting Nektar
Yahoo/Zacks.com
Tuesday, September 22, 2009 - 7:39pm
tags:
AstraZeneca, Nektar, Abbott Laboratories, licensing
Good News for Top of AMGN's Pipeline
Yahoo/Zacks.com
Tuesday, September 22, 2009 - 7:38pm
tags:
Amgen, GSK, Novartis, denosumab
Who's the greenest pharma of all?
Fierce Pharma
Tuesday, September 22, 2009 - 11:42am
tags:
pharma industry, environmental concerns
The Jury's Out On Dendreon
CNBC
Tuesday, September 22, 2009 - 11:40am
tags:
Dendreon
FDA to review CombinatoRx drug application
Bizjournals.com
Tuesday, September 22, 2009 - 10:44am
tags:
FDA, CombinatoRx, Exalgo

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.